Schedule III
Sec. 8. (a) The controlled substances listed in this section are
included in schedule III.
(b) Stimulants. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation
which contains any quantity of the following substances having a
stimulant effect on the central nervous system, including its salts,
isomers (whether optical, position, or geometric), and salts of such
isomers whenever the existence of such salts, isomers, and salts of
isomers is possible within the specific chemical designation:
(1) Those compounds, mixtures, or preparations in dosage unit
form containing any stimulant substances listed in schedule II
which compounds, mixtures, or preparations were listed on
April 1, 1986, as excepted compounds under 21 CFR 1308.32,
and any other drug of the quantitative composition shown in
that list for those drugs or that is the same except that it
contains a lesser quantity of controlled substances (1405).
(2) Benzphetamine (1228).
(3) Chlorphentermine (1645).
(4) Clortermine (1647).
(5) Phendimetrazine (1615).
(c) Depressants. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture, or preparation
which contains any quantity of the following substances having a
depressant effect on the central nervous system:
(1) Any compound, mixture, or preparation containing:
(A) amobarbital (2125);
(B) secobarbital (2315);
(C) pentobarbital (2270); or
(D) any of their salts;
and one (1) or more other active medicinal ingredients which
are not listed in any schedule.
(2) Any suppository dosage form containing:
(A) amobarbital (2125);
(B) secobarbital (2315);
(C) pentobarbital (2270); or
(D) any of their salts;
and approved by the Food and Drug Administration for
marketing only as a suppository.
(3) Any substance which contains any quantity of a derivative
of barbituric acid, or any salt thereof (2100).
(4) Chlorhexadol (2510).
(5) Glutethimide (2550).
(6) Lysergic acid (7300).
(7) Lysergic acid amide (7310).
(8) Methyprylon (2575).
(9) Sulfondiethylmethane (2600).
(10) Sulfonethylmethane (2605).
(11) Sulfonmethane (2610).
(12) A combination product containing tiletimine and
zolazepam (Telazol) (7295).
(13) Any drug product containing gamma-hydroxybutyric acid,
including its salts, isomers, and salts of isomers, for which an
application is approved under section 505 of the federal Food,
Drug and Cosmetic Act, 21 U.S.C. 301 et seq. (2012).
(d) Nalorphine (a narcotic drug) (9400).
(e) Narcotic Drugs. Unless specifically excepted or unless listed
in another schedule, any material, compound, mixture, or preparation
containing any of the following narcotic drugs, or their salts
calculated as the free anhydrous base or alkaloid, in the following
limited quantities:
(1) Not more than 1.8 grams of codeine, per 100 milliliters or
not more than 90 milligrams per dosage unit, with an equal or
greater quantity of an isoquinoline alkaloid of opium (9803).
(2) Not more than 1.8 grams of codeine, per 100 milliliters or
not more than 90 milligrams per dosage unit, with one (1) or
more active, nonnarcotic ingredients in recognized therapeutic
amounts (9804).
(3) Not more than 300 milligrams of dihydrocodeinone, per 100
milliliters or not more than 15 milligrams per dosage unit, with
a fourfold or greater quantity of an isoquinoline alkaloid of
opium (9805).
(4) Not more than 300 milligrams of dihydrocodeinone, per 100
milliliters or not more than 15 milligrams per dosage unit, with
one (1) or more active nonnarcotic ingredients in recognized
therapeutic amounts (9806).
(5) Not more than 1.8 grams of dihydrocodeine, per 100
milliliters or not more than 90 milligrams per dosage unit, with
one (1) or more active, nonnarcotic ingredients in recognized
therapeutic amounts (9807).
(6) Not more than 300 milligrams of ethylmorphine, per 100
milliliters or not more than 15 milligrams per dosage unit, with
one (1) or more active, nonnarcotic ingredients in recognized
therapeutic amounts (9808).
(7) Not more than 500 milligrams of opium per 100 milliliters
or per 100 grams or not more than 25 milligrams per dosage
unit, with one (1) or more active, nonnarcotic ingredients in
recognized therapeutic amounts (9809).
(8) Not more than 50 milligrams of morphine, per 100
milliliters or per 100 grams with one (1) or more active
nonnarcotic ingredients in recognized therapeutic amounts
(9810).
(f) Anabolic steroid (as defined in 21 U.S.C. 802(41)(A) and 21
U.S.C. 802(41)(B)).
(g) The board shall except by rule any compound, mixture, or
preparation containing any stimulant or depressant substance listed
in subsections (b) through (e) from the application of any part of this
article if the compound, mixture, or preparation contains one (1) or
more active medicinal ingredients not having a stimulant or
depressant effect on the central nervous system, and if the admixtures
are included therein in combinations, quantity, proportion, or
concentration that vitiate the potential for abuse of the substances
which have a stimulant or depressant effect on the central nervous
system.
(h) Any material, compound, mixture, or preparation which
contains any quantity of Ketamine.
As added by Acts 1976, P.L.148, SEC.7. Amended by Acts 1977,
P.L.2, SEC.86; Acts 1979, P.L.303, SEC.5; Acts 1981, P.L.170,
SEC.4; P.L.333-1983, SEC.3; P.L.200-1987, SEC.10; P.L.48-1991,
SEC.76; P.L.1-1994, SEC.171; P.L.31-1998, SEC.10; P.L.288-2001,
SEC.16.
Last modified: May 24, 2006